Updates in Pediatric Anesthesia MAY 12, 2017 BRIAN GILLISS MD PEDIATRIC ANESTHESIA KAISER SAN FRANCISCO SELECTED SLIDES DRAFTED BY KAREN BOCKLI MD NEONATOLOGY, KAISER SAN FRANCISCO Disclosure Kaiser Permanente South San Francisco has determined that the speaker (Dr. Gilliss, Dr. Bockli) and the planning committee (Dr. Becker, Dr. Yap, Dr. Ginsberg, Rebecca Bayrer, Heather Miller) for this activity do not have any relevant financial relationships. Kaiser Permanente South San Francisco takes responsibility for the content, quality, and scientific integrity of this CME Activity. Kaiser Permanente does not endorse any brand-name products. Objectives Review new literature on pediatric anesthesia and discuss implications to current practice. Address new concern of FDA release statement on exposure to anesthesia for our pediatric population. Manage pediatric emergencies according to latest guidelines. Diagnose pediatric emergence delirium and apply latest treatment recommendations. Recent Literature Not much to say . . . Implementation of Cognitive Aids SPA Pedi Crisis Cards Sugammadex in children . . . except about neurotoxicity Recent Literature http://www.pedsanesthesia.org/wp-content/uploads/2017/03/Critical_Event_Checklists.pdf Clebone. Anesth Analg. 2017 Mar;124(3):900-907 Recent Literature Volume 27 (2) Roughly 6 trials have been done (n~20-80), all with rocuronium Mixed surgical, oncology, CHD, neonates Case reports in myasthenia, myotonic dystrophy, and Duchenne’s Typical time to reversal 30s-90s Anaphylaxis rate 0.3%, almost entirely within 4min What about emergent reintubation? Discussion of KP SSF practice What cases do you do/transfer? ENT: myringotomy, T&A, sleep endoscopy, hearing tests ortho/podiatry: elbow CRPP, club foot Urology: circumcision, orchiopexy Gen Surg: appy IR: line revisions ED: intubation, difficult PIV, LP assistance How do you do your T&A? Premed, decadron, tylenol, precedex, zofran, opiate
Description: